Following coma due to severe brain injury, a patient can wake up or progress into an Unresponsive wakefulness syndrome (UWS) or Minimally Conscious State (MCS). These entities are characterized by preserved wakefulness and completely (UWS) or partially (MCS) impaired awareness. The functional and behavioral outcome of these patients is rather difficult to predict, as many factors come into play, including the type and severity of brain injury and, in particular, the level of awareness, which is assessed by using specific clinical scales that quantify the behavioral responsiveness (e.g., the Coma Recovery Scale-Revised). However, behavioral assessment provides a high level of misdiagnosis (about 40%) (Bender et al., 2015) . In fact, the clinical presentations of MCS and UWS can be relatively similar in many cases (Guldenmund et al., 2012) and could be biased by several sources of false negative results (Majerus et al., 2009; Bruno et al., 2010; Schnakers et al., 2010) . Therefore, supporting the clinical assessment by means of para-clinical approaches is warranted to determine the person's level of wakefulness and awareness, so to classify the disorder of consciousness (DoC) and to define prognosis (functional and behavioral recovery), treatment, and care. Such approaches mainly consist of advanced neurophysiologic (electroencephalographic signal analyses and event-related potentials) and neuroimaging techniques (e.g., functional magnetic resonance imaging, magnetic resonance spectroscopy, diffusion tensor imaging, fiber tracking, and positron emission tomography) highlighting brain responses that can be useful to improve the sensibility and specificity of DoC diagnosis and prognosis. Besides, novel neurophysiologic approaches (including the analysis of electroencephalographic signal following transcranial magnetic, audiomotor, and visuomotor stimulation) have been shown promising to differentiate patients with DoC (Naro et al., 2015a,b,c) .
The interesting work of Tobaldini et al. (2018) in this issue of Clinical Neurophysiology significantly contributes to the bulk of such paraclinical approaches. The authors investigated the effects of nociceptive stimulation on linear and nonlinear heart rate variability (HRV) in a population of patients with chronic UWS and MCS, so to evaluate the cardiac autonomic control. The authors found that nociceptive stimuli induced changes of autonomic function (i.e., an increase in sympathetic and a reduction in vagal tone), with a more evident reduction of autonomic complexity in patients with UWS than in those with MCS. Coherently with their findings, the authors concluded that autonomic assessment might be promising in differentiating between UWS and MCS patients, with particular regard to the cardiac autonomic responses to nociceptive stimuli, and for the bedside identification of patients at higher risk of cardiac mortality.
This work is in keeping with the growing evidence suggesting that the autonomic nervous system (ANS) may play an important role in influencing awareness expression and recovery. In fact, autonomic instability, up to cardiovascular storm, is a well-known negative factor concerning awareness recovery and outcome level (Owens et al., 2006) . Moreover, it has been observed that the degree of dysfunction of specific ANS parameters inversely correlates with the chances of recovery and level of awareness suppression in patients with DoC (Riganello et al., 2015) . ANS disorders mainly depend on a hyper-activity encompassing large-scale networks at central nervous system level, which is secondary to the brain injury-induced thalamo-cortical connectivity breakdown. However, it has been hypothesized that such a hyperactivation may represent an extreme, but dysfunctional, attempt to preserve body system homeostasis and regain awareness (Kassubek et al., 2003; Appelhans and Luecken, 2008; Di Perri et al., 2013) . Finally, a previous work investigating multiple responses (including ultra-late laser-evoked potentials, skin-reflex, and HRV) to nociceptive stimuli in patients with chronic UWS and MCS (Leo et al., 2016) found that patients with MCS disclose significant brain and HVR responses to nociceptive stimuli, whereas patients with UWS do not.
Altogether, these findings support the notion that HRV analysis and, more extensively, cardiac autonomic control can provide complementary information for the bedside identification of awareness and the risk of cardiac mortality in patients with chronic DoC. Therefore, studies aimed at quantifying the differences in spontaneous or stimuli-induced activation of ANS between MCS and UWS patients, as the one by Tobaldini et al., can be useful to differentiate patients with DoC and estimate their outcomes.
Even though the findings on ANS functionality in patients with DoC deserve confirmation in larger-sample studies, they suggest the potential usefulness of combining specific electrophysiological methods with conscientious clinical assessment for allowing precise diagnosis and prognosis of DoC, furnishing a valid support to manage such very fragile and vulnerable patients, and designing patient-tailored neurorehabilitative paradigms.
